[Molecular imaging of tumor blood vessels]

D Tilki1, B Singer, M Seitz

  • 1Urologische Klinik und Poliklinik, Klinikum der Ludwig-Maximilians-Universität, München.

Der Urologe. Ausg. A
|July 20, 2007
PubMed

Insights

New molecular imaging techniques are needed to track tumor vascular remodeling, especially for anti-angiogenic therapy. Current methods lack the resolution to assess microvessel changes, a key indicator of treatment response.

Area of Science:

  • Oncology
  • Vascular Biology
  • Medical Imaging

Context:

  • Anti-angiogenic drugs are increasingly used in cancer therapy.
  • Understanding tumor vascular remodeling is crucial for effective treatment monitoring.
  • Existing imaging techniques (X-ray, CT, MRI, ultrasound) require enhancement.

Purpose:

  • To highlight the need for advanced molecular imaging techniques for tumor angiogenesis.
  • To emphasize the importance of monitoring vascular remodeling in response to anti-angiogenic therapy.
  • To address the limitations of current imaging resolution in evaluating microvessel changes.

Summary:

  • Tumor angiogenesis research has advanced significantly.
  • Anti-angiogenic therapy necessitates improved molecular imaging of vascular remodeling.
  • Current imaging methods are insufficient for assessing microvessel remodeling, a critical early indicator.

Impact:

  • Development of novel imaging approaches to precisely evaluate tumor vascular remodeling.
  • Improved monitoring of anti-angiogenic therapy efficacy.
  • Enhanced understanding of tumor microenvironment dynamics during treatment.